Gene Therapy - Table of Contents alert Volume 23 Issue 7

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 23, Issue 7 (July 2016) In this issue News And Commentaries Original Articles Short Communication Corrigendum Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement We are pleased to announce that the Impact Factor* for Gene Therapy is now 3.242 - an increase from 3.104 last year. GT is ranked 60 of 165 titles in the genetics & heredity category and 39 of 124 titles in the medicine, research & experimental category. The journal would like to thank all our authors, reviewers and readers for their continued support. (*Thomson Reuters, 2015 Journal Citation Reports®)  Submit your research News And Commentaries Top In vivo gene therapy potentials of CRISPR-Cas9 H-Y Xue, X Zhang, Y Wang, L Xiaojie, W-J Dai and Y Xu Gene Ther 2016 23: 557-559; advance online publication, March 31, 2016; 10.1038/gt.2016.25 Full Text Tackling chondrocyte hypertrophy with multifunctional nanoparticles M Bottini, A Magrini, B Fadeel and N Rosato Gene Ther 2016 23: 560-564; advance online publication, April 14, 2016; 10.1038/gt.2016.33 Full Text Original Articles Top Effects of transgene expression level per cell in mice livers on induction of transgene-specific immune responses after hydrodynamic gene transfer Y Yin, Y Takahashi, A Hamana, M Nishikawa and Y Takakura Gene Ther 2016 23: 565-571; advance online publication, March 11, 2016; 10.1038/gt.2016.26 Abstract | Full Text Adenovirus-mediated hAQP1 expression in irradiated mouse salivary glands causes recovery of saliva secretion by enhancing acinar cell volume decrease L Y Teos, C-Y Zheng, X Liu, W D Swaim, C M Goldsmith, A P Cotrim, B J Baum and I S Ambudkar Gene Ther 2016 23: 572-579; advance online publication, March 11, 2016; 10.1038/gt.2016.29 Abstract | Full Text Adenoviral vector encoding soluble Flt-1 engineered human endometrial mesenchymal stem cells effectively regress endometriotic lesions in NOD/SCID mice A R Koippallil Gopalakrishnan, H Pandit, S M Metkari, N Warty and T Madan Gene Ther 2016 23: 580-591; advance online publication, March 18, 2016; 10.1038/gt.2016.30 Abstract | Full Text The relevance of coagulation factor X protection of adenoviruses in human sera OPEN M R Duffy, A Doszpoly, G Turner, S A Nicklin and A H Baker Gene Ther 2016 23: 592-596; advance online publication, March 25, 2016; 10.1038/gt.2016.32 Abstract | Full Text Evaluation of the biological differences of canine and human factor VIII in gene delivery: implications in human hemophilia treatment Q Wang, B Dong, J Firrman, W Wu, S Roberts, A R Moore, L S Liu, M P S Chin, Y Diao, J Kost and W Xiao Gene Ther 2016 23: 597-605; advance online publication, April 11, 2016; 10.1038/gt.2016.34 Abstract | Full Text Development of an AAV9 coding for a 3XFLAG-TALEfrat#8-VP64 able to increase in vivo the human frataxin in YG8R mice OPEN P Chapdelaine, C Gérard, N Sanchez, K Cherif, J Rousseau, D L Ouellet, D Jauvin and J P Tremblay Gene Ther 2016 23: 606-614; advance online publication, May 5, 2016; 10.1038/gt.2016.36 Abstract | Full Text Optimized human CYP4B1 in combination with the alkylator prodrug 4-ipomeanol serves as a novel suicide gene system for adoptive T-cell therapies K Roellecke, E L Virts, R Einholz, K Z Edson, B Altvater, C Rossig, D von Laer, K Scheckenbach, M Wagenmann, D Reinhardt, C M Kramm, A E Rettie, C Wiek and H Hanenberg Gene Ther 2016 23: 615-626; advance online publication, May 19, 2016; 10.1038/gt.2016.38 Abstract | Full Text Short Communication Top Lentivirus pre-packed with Cas9 protein for safer gene editing J G Choi, Y Dang, S Abraham, H Ma, J Zhang, H Guo, Y Cai, J G Mikkelsen, H Wu, P Shankar and N Manjunath Gene Ther 2016 23: 627-633; advance online publication, April 7, 2016; 10.1038/gt.2016.27 Abstract | Full Text Corrigendum Top A new plasmid-based microRNA inhibitor system that inhibits microRNA families in transgenic mice and cells: a potential new therapeutic reagent H Cao, W Yu, X Li, J Wang, S Gao, N E Holton, S Eliason, T Sharp and B A Amendt Gene Ther 2016 23: 634; 10.1038/gt.2016.44 Full Text Advertisement Take a look at our new Editor's Choice page   Gene Therapy is delighted to share with you an Editor's Choice selection of key papers that highlight some of the best current research published in the journal. These papers showcase the breadth of scope and coverage that this journal consistently delivers to its readers, and have been selected because readers will find them particularly interesting or useful.  View the Editor's Coice articles Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.